Article

Kellogg Eye Center expands with new tower

The Brehm Tower at the W.K. Kellogg Eye Center Complex, a $132 million, 230,000-square-foot, eight-story facility, opened March 1. It is adjacent to the existing Kellogg Eye Center research tower.

Ann Arbor, MI

-The Brehm Tower at the W.K. Kellogg Eye Center Complex, a $132 million, 230,000-square-foot, eight-story facility, opened March 1. It is adjacent to the existing Kellogg Eye Center research tower at the University of Michigan.

The new building includes seven eye-care clinics, high-tech surgical suites, and suites for refractive surgery and cosmetic surgery. The upper floors house the Brehm Center for Diabetes Research and laboratories for vision scientists. The proximity of the diabetes and eye centers is expected to help University of Michigan researchers in those fields collaborate on studies of eye-related complications of diabetes, notably diabetic retinopathy.

“This project has significantly expanded the eye center, allowing us to serve a rapidly growing and aging patient population and to expand the critical mass of scientists to advance research aimed at preserving vision,” said Paul R. Lichter, MD, chairman of the Department of Ophthalmology and Visual Sciences and director of the Kellogg Eye Center. “We often say that we help patients one at a time in our clinics and we help the world in our labs. That’s what we will do in this new building.”

The University of Michigan Health System formally will dedicate the building April 23. Festivities will include tours, Kellogg’s annual spring conference for ophthalmologists, and remarks by Francis S. Collins, MD, PhD, director of the National Institutes of Health, and Paul A. Sieving, MD, PhD, director of the National Eye Institute.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.